fisher & paykel healthcare limited
fisher & paykel healthcare limited Company Information
Company Number
02887128
Website
http://fphcare.comRegistered Address
16 cordwallis park, clivemont road, maidenhead, berkshire, SL6 7BU
Industry
Other human health activities
Telephone
01628626136
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
fisher & paykel healthcare corp ltd 100%
fisher & paykel healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of FISHER & PAYKEL HEALTHCARE LIMITED at £20.1m based on a Turnover of £31.6m and 0.64x industry multiple (adjusted for size and gross margin).
fisher & paykel healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of FISHER & PAYKEL HEALTHCARE LIMITED at £9m based on an EBITDA of £1.5m and a 5.85x industry multiple (adjusted for size and gross margin).
fisher & paykel healthcare limited Estimated Valuation
Pomanda estimates the enterprise value of FISHER & PAYKEL HEALTHCARE LIMITED at £34.6m based on Net Assets of £14.9m and 2.32x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Fisher & Paykel Healthcare Limited Overview
Fisher & Paykel Healthcare Limited is a live company located in maidenhead, SL6 7BU with a Companies House number of 02887128. It operates in the other human health activities sector, SIC Code 86900. Founded in January 1994, it's largest shareholder is fisher & paykel healthcare corp ltd with a 100% stake. Fisher & Paykel Healthcare Limited is a mature, large sized company, Pomanda has estimated its turnover at £31.6m with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Fisher & Paykel Healthcare Limited Health Check
Pomanda's financial health check has awarded Fisher & Paykel Healthcare Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 9 areas for improvement. Company Health Check FAQs
3 Strong
0 Regular
9 Weak
Size
annual sales of £31.6m, make it larger than the average company (£720.8k)
£31.6m - Fisher & Paykel Healthcare Limited
£720.8k - Industry AVG
Growth
3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (5.3%)
1% - Fisher & Paykel Healthcare Limited
5.3% - Industry AVG
Production
with a gross margin of 28.5%, this company has a higher cost of product (35.9%)
28.5% - Fisher & Paykel Healthcare Limited
35.9% - Industry AVG
Profitability
an operating margin of 4.6% make it less profitable than the average company (6%)
4.6% - Fisher & Paykel Healthcare Limited
6% - Industry AVG
Employees
with 78 employees, this is above the industry average (19)
78 - Fisher & Paykel Healthcare Limited
19 - Industry AVG
Pay Structure
on an average salary of £53.6k, the company has a higher pay structure (£24.6k)
£53.6k - Fisher & Paykel Healthcare Limited
£24.6k - Industry AVG
Efficiency
resulting in sales per employee of £404.6k, this is more efficient (£43.2k)
£404.6k - Fisher & Paykel Healthcare Limited
£43.2k - Industry AVG
Debtor Days
it gets paid by customers after 39 days, this is later than average (22 days)
39 days - Fisher & Paykel Healthcare Limited
22 days - Industry AVG
Creditor Days
its suppliers are paid after 3 days, this is quicker than average (18 days)
3 days - Fisher & Paykel Healthcare Limited
18 days - Industry AVG
Stock Days
it holds stock equivalent to 187 days, this is more than average (9 days)
187 days - Fisher & Paykel Healthcare Limited
9 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 23 weeks, this is less cash available to meet short term requirements (141 weeks)
23 weeks - Fisher & Paykel Healthcare Limited
141 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 25.4%, this is a higher level of debt than the average (21.7%)
25.4% - Fisher & Paykel Healthcare Limited
21.7% - Industry AVG
FISHER & PAYKEL HEALTHCARE LIMITED financials
Fisher & Paykel Healthcare Limited's latest turnover from March 2023 is £31.6 million and the company has net assets of £14.9 million. According to their latest financial statements, Fisher & Paykel Healthcare Limited has 78 employees and maintains cash reserves of £1.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 31,558,000 | 30,222,000 | 41,070,000 | 30,471,000 | 26,600,000 | 24,958,000 | 23,223,000 | 20,116,000 | 18,266,887 | 15,664,608 | 14,109,244 | 11,391,319 | 10,385,506 | 10,794,639 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 22,571,000 | 22,509,000 | 33,306,000 | 23,363,000 | 20,367,000 | 19,083,000 | 17,475,000 | 14,741,000 | 13,423,174 | 10,893,216 | 9,784,985 | 7,708,399 | 7,113,545 | 7,446,487 |
| Gross Profit | 8,987,000 | 7,713,000 | 7,764,000 | 7,108,000 | 6,233,000 | 5,875,000 | 5,748,000 | 5,375,000 | 4,843,713 | 4,771,392 | 4,324,259 | 3,682,920 | 3,271,961 | 3,348,152 |
| Admin Expenses | 7,541,000 | 6,376,000 | 6,315,000 | 5,773,000 | 5,563,000 | 5,247,000 | 4,746,000 | 4,208,000 | 3,714,152 | 3,650,699 | 3,422,109 | 3,038,521 | 3,122,959 | 3,093,405 |
| Operating Profit | 1,446,000 | 1,337,000 | 1,449,000 | 1,335,000 | 670,000 | 628,000 | 1,002,000 | 1,167,000 | 1,129,561 | 1,120,693 | 902,150 | 644,399 | 149,002 | 254,747 |
| Interest Payable | 64,000 | 45,000 | 35,000 | 14,000 | 7,000 | 7,000 | 5,000 | 0 | 9,409 | 12,253 | 11,360 | 12,667 | 13,117 | 11,488 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 162,000 | 418 | 604 | 802 | 1,251 | 528 | 1,396 |
| Pre-Tax Profit | 3,194,000 | 8,880,000 | 4,677,000 | 3,180,000 | 3,147,000 | 1,564,000 | 2,240,000 | 4,197,000 | 2,345,241 | 3,730,493 | 1,516,404 | 1,283,369 | 1,073,786 | 1,103,418 |
| Tax | -646,000 | -219,000 | -299,000 | -255,000 | -150,000 | -136,000 | -152,000 | -187,000 | -211,137 | -247,746 | -212,503 | -173,530 | -41,633 | -88,368 |
| Profit After Tax | 2,548,000 | 8,661,000 | 4,378,000 | 2,925,000 | 2,997,000 | 1,428,000 | 2,088,000 | 4,010,000 | 2,134,104 | 3,482,747 | 1,303,901 | 1,109,839 | 1,032,153 | 1,015,050 |
| Dividends Paid | 0 | 0 | 5,000,000 | 2,400,000 | 3,150,000 | 1,400,000 | 1,500,000 | 3,808,000 | 1,800,000 | 3,200,000 | 856,000 | 934,249 | 1,031,227 | 996,443 |
| Retained Profit | 2,548,000 | 8,661,000 | -622,000 | 525,000 | -153,000 | 28,000 | 588,000 | 202,000 | 334,104 | 282,747 | 447,901 | 175,590 | 926 | 18,607 |
| Employee Costs | 4,182,000 | 4,059,000 | 4,057,000 | 3,487,000 | 3,309,000 | 3,092,000 | 2,469,000 | 2,298,486 | 2,205,193 | 2,140,428 | 2,011,022 | 1,984,116 | 1,816,588 | |
| Number Of Employees | 78 | 79 | 76 | 71 | 70 | 65 | 54 | 49 | 50 | 48 | 46 | 46 | 44 | |
| EBITDA* | 1,536,000 | 1,428,000 | 1,525,000 | 1,407,000 | 745,000 | 551,000 | 1,002,000 | 1,216,000 | 1,171,095 | 1,147,647 | 927,505 | 668,641 | 182,640 | 304,495 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 238,000 | 1,398,000 | 1,802,000 | 344,000 | 164,000 | 216,000 | 251,000 | 73,000 | 93,199 | 55,761 | 38,876 | 43,871 | 40,596 | 54,926 |
| Intangible Assets | 1,820,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 1,040,000 | 1,040,000 | 1,040,000 | 1,040,000 | 1,040,000 | 1,040,000 | 1,040,000 | 1,040,000 | 1,039,433 | 1,039,433 | 1,039,433 | 1,039,433 | 1,039,433 | 1,039,433 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 3,098,000 | 2,438,000 | 2,842,000 | 1,384,000 | 1,204,000 | 1,256,000 | 1,291,000 | 1,113,000 | 1,132,632 | 1,095,194 | 1,078,309 | 1,083,304 | 1,080,029 | 1,094,359 |
| Stock & work in progress | 11,601,000 | 12,312,000 | 12,836,000 | 6,281,000 | 6,129,000 | 6,144,000 | 5,896,000 | 4,201,000 | 3,820,704 | 3,640,894 | 2,862,784 | 2,156,508 | 1,586,614 | 1,559,317 |
| Trade Debtors | 3,381,000 | 2,663,000 | 3,654,000 | 5,347,000 | 2,907,000 | 2,894,000 | 2,404,000 | 2,484,000 | 2,077,653 | 1,991,176 | 1,932,585 | 1,728,962 | 1,086,271 | 1,127,170 |
| Group Debtors | 10,000 | 678,000 | 20,000 | 38,000 | 26,000 | 0 | 2,000 | 218,000 | 265,592 | 4,441 | 0 | 15,431 | 94,989 | 9,120 |
| Misc Debtors | 411,000 | 335,000 | 375,000 | 356,000 | 519,000 | 359,000 | 347,000 | 822,000 | 659,769 | 207,233 | 246,422 | 250,035 | 345,128 | 285,011 |
| Cash | 1,457,000 | 1,842,000 | 739,000 | 279,000 | 197,000 | 175,000 | 71,000 | 28,000 | 82,557 | 116,023 | 35,063 | 49,520 | 42,834 | 73,005 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 16,860,000 | 17,830,000 | 17,624,000 | 12,301,000 | 9,778,000 | 9,572,000 | 8,720,000 | 7,753,000 | 6,906,275 | 5,959,767 | 5,076,854 | 4,200,456 | 3,155,836 | 3,053,623 |
| total assets | 19,958,000 | 20,268,000 | 20,466,000 | 13,685,000 | 10,982,000 | 10,828,000 | 10,011,000 | 8,866,000 | 8,038,907 | 7,054,961 | 6,155,163 | 5,283,760 | 4,235,865 | 4,147,982 |
| Bank overdraft | 0 | 0 | 0 | 401,000 | 226,000 | 506,000 | 259,000 | 573,000 | 448,097 | 534,808 | 548,461 | 396,509 | 244,608 | 411,832 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 236,000 | 187,000 | 343,000 | 718,000 | 1,024,000 | 592,000 | 289,000 | 575,000 | 302,302 | 354,228 | 456,784 | 620,144 | 222,022 | 293,855 |
| Group/Directors Accounts | 894,000 | 4,020,000 | 11,452,000 | 6,415,000 | 5,054,000 | 4,920,000 | 4,623,000 | 3,445,000 | 3,506,279 | 2,907,061 | 2,197,927 | 1,907,386 | 1,511,552 | 1,390,568 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 457,000 | 383,000 | 406,000 | 140,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 1,673,000 | 1,518,000 | 2,323,000 | 1,570,000 | 971,000 | 989,000 | 1,085,000 | 1,143,000 | 876,902 | 701,099 | 690,889 | 554,922 | 637,338 | 442,522 |
| total current liabilities | 3,260,000 | 6,108,000 | 14,524,000 | 9,244,000 | 7,275,000 | 7,007,000 | 6,256,000 | 5,736,000 | 5,133,580 | 4,497,196 | 3,894,061 | 3,478,961 | 2,615,520 | 2,538,777 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 1,398,000 | 901,000 | 1,248,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 403,000 | 914,000 | 942,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 91,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 1,801,000 | 1,815,000 | 2,190,000 | 91,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 5,061,000 | 7,923,000 | 16,714,000 | 9,335,000 | 7,275,000 | 7,007,000 | 6,256,000 | 5,736,000 | 5,133,580 | 4,497,196 | 3,894,061 | 3,478,961 | 2,615,520 | 2,538,777 |
| net assets | 14,897,000 | 12,345,000 | 3,752,000 | 4,350,000 | 3,707,000 | 3,821,000 | 3,755,000 | 3,130,000 | 2,905,327 | 2,557,765 | 2,261,102 | 1,804,799 | 1,620,345 | 1,609,205 |
| total shareholders funds | 14,897,000 | 12,345,000 | 3,752,000 | 4,350,000 | 3,707,000 | 3,821,000 | 3,755,000 | 3,130,000 | 2,905,327 | 2,557,765 | 2,261,102 | 1,804,799 | 1,620,345 | 1,609,205 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 1,446,000 | 1,337,000 | 1,449,000 | 1,335,000 | 670,000 | 628,000 | 1,002,000 | 1,167,000 | 1,129,561 | 1,120,693 | 902,150 | 644,399 | 149,002 | 254,747 |
| Depreciation | 90,000 | 91,000 | 76,000 | 72,000 | 75,000 | -77,000 | 49,000 | 41,534 | 26,954 | 25,355 | 24,242 | 33,638 | 49,748 | |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -646,000 | -219,000 | -299,000 | -255,000 | -150,000 | -136,000 | -152,000 | -187,000 | -211,137 | -247,746 | -212,503 | -173,530 | -41,633 | -88,368 |
| Stock | -711,000 | -524,000 | 6,555,000 | 152,000 | -15,000 | 248,000 | 1,695,000 | 380,296 | 179,810 | 778,110 | 706,276 | 569,894 | 27,297 | 1,559,317 |
| Debtors | 126,000 | -373,000 | -1,692,000 | 2,289,000 | 199,000 | 500,000 | -771,000 | 520,986 | 800,164 | 23,843 | 184,579 | 468,040 | 105,087 | 1,421,301 |
| Creditors | 49,000 | -156,000 | -375,000 | -306,000 | 432,000 | 303,000 | -286,000 | 272,698 | -51,926 | -102,556 | -163,360 | 398,122 | -71,833 | 293,855 |
| Accruals and Deferred Income | -356,000 | -833,000 | 1,695,000 | 599,000 | -18,000 | -96,000 | -58,000 | 266,098 | 175,803 | 10,210 | 135,967 | -82,416 | 194,816 | 442,522 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | 1,168,000 | 1,117,000 | -2,317,000 | -996,000 | 825,000 | -126,000 | 666,514 | 103,861 | 5,602 | -203,246 | -227,117 | 131,606 | -2,028,114 | |
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 567 | 0 | 0 | 0 | 0 | 0 | 1,039,433 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -3,126,000 | -7,432,000 | 5,037,000 | 1,361,000 | 134,000 | 297,000 | 1,178,000 | -61,279 | 599,218 | 709,134 | 290,541 | 395,834 | 120,984 | 1,390,568 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 571,000 | -370,000 | 1,514,000 | 140,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | -91,000 | 91,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -64,000 | -45,000 | -35,000 | -14,000 | -7,000 | -7,000 | -5,000 | 162,000 | -8,991 | -11,649 | -10,558 | -11,416 | -12,589 | -10,092 |
| cash flow from financing | -2,615,000 | -7,915,000 | 6,449,000 | 1,696,000 | 166,000 | 328,000 | 1,210,000 | 123,394 | 603,685 | 711,401 | 288,385 | 393,282 | 118,609 | 2,971,074 |
| cash and cash equivalents | ||||||||||||||
| cash | -385,000 | 1,103,000 | 460,000 | 82,000 | 22,000 | 104,000 | 43,000 | -54,557 | -33,466 | 80,960 | -14,457 | 6,686 | -30,171 | 73,005 |
| overdraft | 0 | 0 | -401,000 | 175,000 | -280,000 | 247,000 | -314,000 | 124,903 | -86,711 | -13,653 | 151,952 | 151,901 | -167,224 | 411,832 |
| change in cash | -385,000 | 1,103,000 | 861,000 | -93,000 | 302,000 | -143,000 | 357,000 | -179,460 | 53,245 | 94,613 | -166,409 | -145,215 | 137,053 | -338,827 |
fisher & paykel healthcare limited Credit Report and Business Information
Fisher & Paykel Healthcare Limited Competitor Analysis
Perform a competitor analysis for fisher & paykel healthcare limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
fisher & paykel healthcare limited Ownership
FISHER & PAYKEL HEALTHCARE LIMITED group structure
Fisher & Paykel Healthcare Limited has no subsidiary companies.
Ultimate parent company
FISHER & PAYKEL HEALTHCARE CORP LTD
#0026872
1 parent
FISHER & PAYKEL HEALTHCARE LIMITED
02887128
fisher & paykel healthcare limited directors
Fisher & Paykel Healthcare Limited currently has 4 directors. The longest serving directors include Mr Paul Shearer (Jan 1994) and Mr Patrick McSweeny (Sep 2012).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Paul Shearer | 65 years | Jan 1994 | - | Director | |
| Mr Patrick McSweeny | 65 years | Sep 2012 | - | Director | |
| Mr Lewis Gradon | 63 years | Mar 2016 | - | Director | |
| Mr Samuel Frame | 41 years | Mar 2023 | - | Director |
P&L
March 2023turnover
31.6m
+4%
operating profit
1.4m
+8%
gross margin
28.5%
+11.58%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
14.9m
+0.21%
total assets
20m
-0.02%
cash
1.5m
-0.21%
net assets
Total assets minus all liabilities
fisher & paykel healthcare limited company details
company number
02887128
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
January 1994
age
30
accounts
Full Accounts
ultimate parent company
previous names
N/A
incorporated
UK
address
16 cordwallis park, clivemont road, maidenhead, berkshire, SL6 7BU
last accounts submitted
March 2023
fisher & paykel healthcare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to fisher & paykel healthcare limited.
fisher & paykel healthcare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
